PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation

Pulak Kar,Chatrin Chatrin,Nina Đukić,Osamu Suyari,Marion Schuller,Kang Zhu,Evgeniia Prokhorova,Nicolas Bigot,Domagoj Baretić,Juraj Ahel,Jonas Damgaard Elsborg,Michael L Nielsen,Tim Clausen,Sébastien Huet,Mario Niepel,Sumana Sanyal,Dragana Ahel,Rebecca Smith,Ivan Ahel

DOI: https://doi.org/10.1038/s44318-024-00126-0

Abstract:PARP-catalysed ADP-ribosylation (ADPr) is important in regulating various cellular pathways. Until recently, PARP-dependent mono-ADP-ribosylation has been poorly understood due to the lack of sensitive detection methods. Here, we utilised an improved antibody to detect mono-ADP-ribosylation. We visualised endogenous interferon (IFN)-induced ADP-ribosylation and show that PARP14 is a major enzyme responsible for this modification. Fittingly, this signalling is reversed by the macrodomain from SARS-CoV-2 (Mac1), providing a possible mechanism by which Mac1 counteracts the activity of antiviral PARPs. Our data also elucidate a major role of PARP9 and its binding partner, the E3 ubiquitin ligase DTX3L, in regulating PARP14 activity through protein-protein interactions and by the hydrolytic activity of PARP9 macrodomain 1. Finally, we also present the first visualisation of ADPr-dependent ubiquitylation in the IFN response. These approaches should further advance our understanding of IFN-induced ADPr and ubiquitin signalling processes and could shed light on how different pathogens avoid such defence pathways.